Cutaneous leishmaniasis
ICD-10 B55.1 · ICD-11 1F54.1

Leishmania panamensis cutaneous leishmaniasis — what to do when local treatment did not achieve healing

This protocol applies to patients with cutaneous leishmaniasis specifically caused by Leishmania panamensis in whom the initial course of local therapy has not resulted in complete reepithelialization of the lesion.

First-line local therapy — topical paromomycin/methylbenzethonium chloride ointment or local heat therapy — did not achieve the required goal: complete reepithelialization (healing) of the cutaneous lesion. Non-achievement of this target is the criterion that triggers escalation to the current protocol.

Following local treatment failure, the structured protocol defines systemic treatment as the next step, with specific options addressing cases involving multiple lesions or a large single lesion — the full regimen, selection criteria, and sequencing are in the complete protocol.

References

DOI: 10.1111/jtm.12089

  • Treatment of L. panamensis
  • 1. Miltefosine (50 mg tid × 28 days) [A]
  • 2. Pentamidine isethionate (4 mg/kg, three infusions over 5 days) [A]
  • 3. Ketoconazole (600 mg × 28 days) [B]
  • 4. Pentavalent antimonials (Sb 20 mg/kg for 20 days) [A]
  • Treatment failure is present when reepithelialization is incomplete 3 months after starting therapy.
View source ↗